Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas
Public ClinicalTrials.gov record NCT00043979. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pilot Study of Allogeneic/Syngeneic Blood Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas
Study identification
- NCT ID
- NCT00043979
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Cancer Institute (NCI)
- NIH
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- F-18 Fluorodeoxyglucose Drug
- Filgrastim Drug
- Peripheral Blood Stem Cell donation Procedure
- cyclophosphamide Drug
- cyclosporine Drug
- doxorubicin hydrochloride Drug
- etoposide Drug
- fludarabine phosphate Drug
- melphalan Drug
- peripheral blood stem cell transplantation Procedure
- prednisone Drug
- sirolimus Drug
- tacrolimus Drug
- therapeutic allogeneic lymphocytes Biological
- vincristine sulfate Drug
Drug · Procedure · Biological
Eligibility (public fields only)
- Age range
- 5 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 18, 2002
- Primary completion
- Apr 30, 2009
- Completion
- Dec 13, 2011
- Last update posted
- May 30, 2017
2002 – 2011
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland | 20892 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00043979, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 30, 2017 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00043979 live on ClinicalTrials.gov.